Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99mTc-MSA-ICG for Sentinel Lymph Node Detection in Lung Cancer
NCT05039905Phase 1Unknown
- Sponsor
- Korea University Guro Hospital
- Start
- Feb 2021
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of technetium-99m-human serum albumin-indocyanine green in lung cancer, sponsored by Korea University Guro Hospital. Primary endpoints: Clinical chemistry examination, Hematology examination and 3 more. Status: unknown.
02
Drugs
technetium-99m-human serum albumin-indocyanine green
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT05039905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05039905.